Some studies have demonstrated the concept of delivering Fc-fusion proteins with the help of oncolytic viruses such as SIRPα-Fc fusion protein against ovarian cancer [50], expression of antibody in HSV-1 oncolytic virus against glioblastoma [51], and adenovirus against breast cancer in mouse model [52]. This evidence concerns the gene SIRPA and ovarian carcinoma.